Paper Details

  1. Home
  2. Paper Details

Optimal therapeutic regimen of famotidine based on plasma concentrations in patients with chronic renal failure.

Author: AndoK, HachisuT, HattoriY, OdaY, YokoyamaT, YoshidaT

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Famotidine, an H2-receptor antagonist, was found to be safe and effective for the treatment of patients with chronic renal failure receiving dialysis. An oral dose of 20 mg immediately after dialysis was optimal.
Paper Details　
Original Abstract of the Article :
An oral therapeutic regimen of famotidine, a histamine H2-receptor antagonist, was evaluated in patients with chronic renal failure who were receiving dialysis three times a week. Measurements of the half-life, bioavailability, and dialysis elimination rate were performed. The half-life of famotidin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2905936

データ提供：米国国立医学図書館（NLM）
in preparation
Date :
  1. Date Completed 1989-03-16
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2905936

DOI: Digital Object Identifier

2905936

Related Literature

Article Analysis
・Side Effects of famotidine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.